Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of 14 Days of Oral Treatment with AMG 837 in Type 2 Diabetic Patients

Sponsor ID

20060271

Clinicaltrials.gov ID

EUCTIS ID

N/A

EudraCT ID

N/A

Study Details

Phase

Phase 1

Product

N/A

Type

Interventional

Masking

N/A

Enrollment

N/A

Additional Study Details

Primary Outcome Measures

Not Available

Secondary Outcome Measures

Not Available

Study Synopsis

Available Language(s): English

No locations found.